HTR1A and schizophrenia: For example, 5-HT1A receptor activation has been proposed as a target for the development of cognitive enhancers for treatment of cognitive dysfunction in schizophrenia, notably via stimulation of dopamine release in key regions such as the frontal cortex11,23.